198 related articles for article (PubMed ID: 9219378)
21. The impact of illicit drug market changes on health agency operations in Sydney, Australia.
Gibson A; Day C; Degenhardt L
J Subst Abuse Treat; 2005 Jan; 28(1):35-40. PubMed ID: 15723730
[TBL] [Abstract][Full Text] [Related]
22. Australian heroin seizures and the causes of the 2001 heroin shortage.
Jiggens J
Int J Drug Policy; 2008 Aug; 19(4):273-8. PubMed ID: 17920258
[TBL] [Abstract][Full Text] [Related]
23. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.
Wood E; Tyndall MW; Spittal PM; Li K; Anis AH; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT
CMAJ; 2003 Jan; 168(2):165-9. PubMed ID: 12538544
[TBL] [Abstract][Full Text] [Related]
24. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
Morgan O; Griffiths C; Hickman M
Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
[TBL] [Abstract][Full Text] [Related]
25. Seeking truth in heroin indicators: the case of New York City.
Frank B; Schmeidler J; Johnson B; Lipton DS
Drug Alcohol Depend; 1978 Sep; 3(5):345-58. PubMed ID: 710265
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
27. The Singapore heroin control programme.
McGlothlin WH
Bull Narc; 1980; 32(1):1-14. PubMed ID: 6905766
[TBL] [Abstract][Full Text] [Related]
28. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Darke S; Ross J; Teesson M
Drug Alcohol Rev; 2007 Jan; 26(1):49-54. PubMed ID: 17364836
[TBL] [Abstract][Full Text] [Related]
29. What is the average price of an illicit drug?
Caulkins JP
Addiction; 1994 Jul; 89(7):815-9. PubMed ID: 8081179
[TBL] [Abstract][Full Text] [Related]
30. Impact of the heroin 'drought' on patterns of drug use and drug-related harms.
Longo MC; Henry-Edwards SM; Humeniuk RE; Christie P; Ali RL
Drug Alcohol Rev; 2004 Jun; 23(2):143-50. PubMed ID: 15370019
[TBL] [Abstract][Full Text] [Related]
31. Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia.
Roxburgh A; Degenhardt L; Breen C
Drug Alcohol Rev; 2004 Sep; 23(3):287-94. PubMed ID: 15370008
[TBL] [Abstract][Full Text] [Related]
32. Changes in Canadian heroin supply coinciding with the Australian heroin shortage.
Wood E; Stoltz JA; Li K; Montaner JS; Kerr T
Addiction; 2006 May; 101(5):689-95. PubMed ID: 16669902
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
34. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS).
Darke S; Topp I; Kaye H; Hall W
Addiction; 2002 Feb; 97(2):179-86. PubMed ID: 11860389
[TBL] [Abstract][Full Text] [Related]
35. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.
Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P
Addiction; 2015 Jan; 110(1):120-8. PubMed ID: 25220170
[TBL] [Abstract][Full Text] [Related]
36. The ACT heroin trial proposal: an overview. Australian Capital Territory.
Bammer G; Douglas RM
Med J Aust; 1996 Jun; 164(11):690-2. PubMed ID: 8657034
[No Abstract] [Full Text] [Related]
37. Identification and quantification of change in Australian illicit drug markets.
Gilmour S; Koch I; Degenhardt L; Day C
BMC Public Health; 2006 Aug; 6():200. PubMed ID: 16884546
[TBL] [Abstract][Full Text] [Related]
38. Determinants of heroin retail prices in metropolitan France: Discounts, purity and local markets.
Lahaie E; Janssen E; Cadet-Taïrou A
Drug Alcohol Rev; 2016 Sep; 35(5):597-604. PubMed ID: 26660876
[TBL] [Abstract][Full Text] [Related]
39. Drug affordability-potential tool for comparing illicit drug markets.
Groshkova T; Cunningham A; Royuela L; Singleton N; Saggers T; Sedefov R
Int J Drug Policy; 2018 Jun; 56():187-196. PubMed ID: 29459212
[TBL] [Abstract][Full Text] [Related]
40. Beyond neoclassical economics: Social process, agency and the maintenance of order in an Australian illicit drug marketplace.
Dwyer R; Moore D
Int J Drug Policy; 2010 Sep; 21(5):390-8. PubMed ID: 20356725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
